CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroi...
Phase 2
Birmingham, Alabama, United States and 24 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Centreville, Alabama, United States and 116 other locations
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase 2
Birmingham, Alabama, United States of America and 83 other locations
inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...
Phase 3
Birmingham, Alabama, United States and 391 other locations
The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compa...
Phase 3
Birmingham, Alabama, United States and 66 other locations
decline in adult patients with uncontrolled moderate to severe asthma.The estimated duration is 4±1 weeks of screening and run-in period, fo...
Phase 4
Cullman, Alabama, United States of America and 259 other locations
This research is being done to test if a drug called omalizumab can help people with Chronic Obstructive Pulmonary Disease (COPD) and allergies.Each...
Phase 2
Birmingham, Alabama, United States and 22 other locations
The primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected...
Phase 1
Birmingham, Alabama, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal